Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming--protein boosting immunization strategies (Q42982697)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2004

Language	Label	Description	Also known as
English	Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming--protein boosting immunization strategies	scientific article published on January 2004

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming--protein boosting immunization strategies (English)

1 reference

Europe PubMed Central

12 November 2017

Japanese encephalitis virus

0 references

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

author name string

Hsued Hwa Wu

1

1 reference

Europe PubMed Central

12 November 2017

Chueh Tan Chen

2

1 reference

Europe PubMed Central

12 November 2017

Yi-Ling Lin

3

1 reference

Europe PubMed Central

12 November 2017

Sho Tone Lee

4

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

22

1 reference

Europe PubMed Central

12 November 2017

5-6

1 reference

Europe PubMed Central

12 November 2017

793-800

1 reference

Europe PubMed Central

12 November 2017

Flavivirus genome organization, expression, and replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Towards a new generation of flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Side-effects with Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by the NS3 gene product

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Immunization with DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.02.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.02.001

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42982697&oldid=1975838008"